Troy, NY, United States of America

Anthony Richard D'Amato

This inventor holds 3 USPTO granted patents. Top assignee: Rensselaer Polytechnic Institute. Active years: 2021-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Anthony Richard D'Amato. Retrieved from https://idiyas.com/inventor/anthony-richard-d-amato

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 66.7

Average Co-Inventor Count = 4.8

ph-index = 1


Company Filing History:


Years Active: 2021-2026

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Innovations in Drug Delivery: The Contributions of Anthony Richard D'Amato

Introduction

Anthony Richard D'Amato is a notable inventor based in Troy, NY (US), recognized for his significant contributions to the field of drug delivery systems. With a total of 3 patents, D'Amato has focused on developing advanced materials that enhance the efficacy and safety of pharmaceutical treatments.

Latest Patents

D'Amato's latest patents include groundbreaking work on controlled drug release from electrospun fibers. This invention relates to the controlled release of an active pharmaceutical ingredient (API) from electrospun fiber scaffolds (EFSs). His second patent involves the synthesis and processing of poly(pro-drug) materials for extended drug release. This innovative material comprises alternating therapeutic compounds and biodegradable hydrocarbyl groups, separated by cleavable linker compounds. The therapeutic compounds, such as estrogen, curcumin, and fingolimod, are designed to degrade in aqueous media at physiological temperature and pH, releasing the therapeutic compounds over extended periods. This zero-order release profile allows for prolonged implantation within a patient, making these materials suitable for various biomedical applications, including veterinary medicine, cancer treatments, birth control, and hormone replacement therapy.

Career Highlights

D'Amato is affiliated with Rensselaer Polytechnic Institute, where he continues to advance research in drug delivery technologies. His work has garnered attention for its potential to revolutionize treatment methodologies in the medical field.

Collaborations

D'Amato collaborates with notable colleagues, including Ryan James Gilbert and Nicholas Schaub, contributing to a dynamic research environment that fosters innovation.

Conclusion

Anthony Richard D'Amato's contributions to drug delivery systems exemplify the impact of innovative thinking in the biomedical field. His patents reflect a commitment to improving patient care through advanced materials and technologies.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…